Jaimin Trivedi, University of Louisville Department of Cardiovascular and Thoracic Surgery
News | Heart Failure
UofL Study Shows Improvement in Heart Transplant Access, Outcomes for Black Patients

February 25, 2022 – Researchers at the University of Louisville analyzed data for heart transplants from 1987 to 2019 to ...

Home February 25, 2022
Home
Intravascular Optical Coherence Tomography (IVOCT)
News | Intravascular Imaging
Dyad Medical Secures FDA Clearance For Cardiac Image Analysis Platform
February 25, 2022 – Dyad Medical, Inc., the developer of the cloud-based AI technology for cardiac image analysis called ...
Home February 25, 2022
Home
GettyImages-173960664
News | Heart Failure
Breakthrough Study Uses Genetic Testing to Evaluate Risk of Heart Disease

February 25, 2022 – Dignity Health in Arizona is launching the first research study in North America in which genetic ...

Home February 25, 2022
Home
The U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of cardiovascular death and hospitalization for heart failure in adults.
News | Heart Failure
FDA Approves Empagliflozin for Reducing Risk of Heart Failure

February 24, 2022 — The U.S. Food and Drug Administration approved Jardiance (empagliflozin) to reduce the risk of ...

Home February 24, 2022
Home
The Department of Justice, together with Attorneys General in Minnesota and New York, filed a civil lawsuit today to stop UnitedHealth Group Incorporated (United) from acquiring Change Healthcare Inc. (Change).
News | Cardiovascular Business
Justice Department Sues to Block UnitedHealth Group’s Acquisition of Change Healthcare

February 24, 2022 — The Department of Justice, together with Attorneys General in Minnesota and New York, filed a civil ...

Home February 24, 2022
Home
We are at the precipice of a huge development in patient care, with the first smart hospital already announced last year in Southeast Asia. To keep pace, governments in the US and Europe need to increase investment in 5G networks, as these will be essential to meet the high network demands.
News | Information Technology
Significant Expansion of 5G Networks Could be the Catalyst Towards Smart Hospitals

February 24, 2022 — Imagine that you are admitted to hospital. A smart scheduling system ensures you have a bed; you ...

Home February 24, 2022
Home
Scientists have already discovered that the gut microbiome is altered in people with chronic heart disease. They subsequently identified compounds that are produced by the diseased microbiome, for instance a bacterial compound called trimethylamine (TMA) that after modification in the liver of the human host causes arteriosclerosis.
News | Heart Failure
Scientists Characterize the Imbalanced Gut Bacteria of Patients with Myocardial Infarction, Angina and Heart Failure
February 21, 2022 – The human gut contains trillions of bacteria, collectively called the gut microbiome, which may have ...
Home February 21, 2022
Home
Researchers at Gladstone; Nearly 1 percent of all children are born with congenital heart disease—a range of potentially life-threatening problems with the structure and function of their hearts. For most children, the precise causes of these frightening defects are unknown.
News | Congenital Heart
Getting to the Heart of Complex Disease
February 21, 2022—Nearly 1 percent of all children are born with congenital heart disease—a range of potentially life ...
Home February 21, 2022
Home
Angioscopic findings in the FPA and infrapopliteal lesions
News | Peripheral Artery Disease (PAD)
Study Finds Ulcerated Plaque in the Femoropopliteal Artery as Source of Arterial Embolism in the Popliteal Arteries
February 21, 2022 – A research group the Department of Cardiovascular Medicine, Osaka City University Graduate School of ...
Home February 21, 2022
Home
An ultrasound is taken of a patient's heart.
News | Cardiac Imaging
A Non-invasive Way to Predict Heart Attack and Stroke
February 21, 2022 – Acute coronary syndromes (such as heart attacks) and strokes are a leading cause of morbidity and ...
Home February 21, 2022
Home
Nuwellis, Inc. has announced the company will evaluate the clinical outcomes and economic value of its Aquadex therapy in comparison to intravenous diuretics for the treatment of fluid overload in patients with worsening heart failure through its randomized controlled trial, Ultrafiltration Versus IV Diuretics in Worsening Heart Failure, the REVERSE-HF Study.
News | Heart Failure
Nuwellis Initiates REVERSE-HF Study to Evaluate Ultrafiltration for Heart Failure Patients with Fluid Overload

February 21, 2022 – Nuwellis, Inc. has announced the company will evaluate the clinical outcomes and economic value of ...

Home February 21, 2022
Home
Pipeline for creating synthetic images and validation process.
News | Cardiac Imaging
New Tool for 3-D Measurement of the Aorta May Identify Fatal Heart Conditions Earlier
February 21, 2022 – Researchers at Michigan Medicine have found a novel method of measuring growth in the body’s largest ...
Home February 21, 2022
Home
Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has developed a new sternal closure device to improve patient recovery after open chest surgery. The patented orthopedic device, made of a high-performance polymer from Evonik, closes and holds the sternum securely together after surgery. 
News | Cardiovascular Surgery
Evonik invests in U.S. start-up offering medical device to improve patient recovery after open-chest surgery
January 18, 2022 – Evonik Venture Capital has invested in CircumFix Solutions, a Tennessee-based start-up that has ...
Home February 18, 2022
Home
Daxor’s Blood Volume (BVA-100) Diagnostic
News | Heart Failure
Study Demonstrates Importance and Clinical Utility of Daxor’s Blood Volume (BVA-100) Diagnostic in the Assessment of Heart Failure
February 18, 2022 – Daxor Corporation, the global leader in blood volume measurement technology, has announced new data ...
Home February 18, 2022
Home
Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of its COBRA-OS (Control of Bleeding, Resuscitation, Arterial Occlusion System), as U.S. and Canadian hospitals continue to implement the life-saving aortic occlusion device during various surgical and emergency cases.
News | Endovascular Aortic Repair
Front Line Medical Technologies Expands Availability of its COBRA-OS

February 18, 2022 – Front Line Medical Technologies, Inc. today announced the expanded availability and distribution of ...

Home February 18, 2022
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now